Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples